“COVID R&D Alliance members are also coordinating with other bodies, including National Institute of Health (NIH), the Bill & Melinda Gates Foundation, U.S. and European trade groups and regulators, among others, to maximize our collective efforts.”
“There are other groups working on solutions as well. Are you coordinating with them?
The need to address COVID-19 is urgent and undeniable. Our efforts are complementary to other accelerators, NGOs, and governmental initiatives—and several of our members have engagement with, and candidates involved in, other programs. We are communicating and sharing our efforts across regions, regulators, and other development efforts, which is key to avoid duplication and inefficiencies as the world races to find therapies for COVID-19.
COVID R&D Alliance members are also coordinating with other bodies, including National Institute of Health (NIH), the Bill & Melinda Gates Foundation, U.S. and European trade groups and regulators, among others, to maximize our collective efforts.
Our work is focused on finding treatments through shared expertise, data, and evaluation of drug candidates. A win for one, is a win for all. The world is counting on us.”
News 
Market Data 
Discover 
